Burney CO Novo Nordisk A S Transaction History

Burney CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$122.71 - $146.91 $3,681 - $4,407	30 Added 1.59%	1,921 $274,000
Q1 2024 May 22, 2024	BUY	$102.11 - $135.92 $193,090 - $257,024	1,891 New	1,891 $242,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $281,638 - $332,297	-2,728 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$93.1 - $112.54 $253,976 - $307,009	2,728 New	2,728 $303,000

1,856

339M

12M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $150B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

Stay updated on Burney CO with notifications on news.